InvestorsHub Logo
Followers 9
Posts 942
Boards Moderated 0
Alias Born 03/20/2019

Re: None

Thursday, 10/01/2020 4:46:24 PM

Thursday, October 01, 2020 4:46:24 PM

Post# of 1109
It appears the lot differences resulted in exposure differences. Small pharma companies generally have shitty quality control compared to bigger companies. A less potent, older lot could be the explanation. Thoughts ?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.